Recently, Barthélemy et al. [67] increased the number of known tau phosphorylated sites to 29, identified pS404 as the most abundant species in the brain, and 12 of these phosphopeptides were common to CSF in AD by an in-depth targeted MS (PRM) analysis, independently of tau concentration. This evidence concerns the gene MAPT and Alzheimer disease.